Brain type I but not type II IL-1 receptors mediate the effects of IL-1β on behavior in mice

被引:32
作者
Cremona, S
Goujon, E
Kelley, KW
Dantzer, R
Parnet, P
机构
[1] INSERM, U394, F-33077 Bordeaux, France
[2] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA
关键词
antibodies; social exploration; mouse;
D O I
10.1152/ajpregu.1998.274.3.R735
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In the immune system, interleukin (IL)-1 beta effects are mediated by the type I IL-1 receptors (IL-1RI), whereas the type II IL-1 receptors (IL-1RII) act as inhibitory receptors. IL-1RI and IL-1RII are also present in the brain. To study their functionality in the brain, mice were centrally treated with neutralizing monoclonal antibody (MAb) directed against IL-1RI (35F5, 1 mu g) or against IL-1RII (4E2, 2 mu g) and were centrally injected with recombinant rat IL-1 beta at a dose (2 ng) that decreased social exploration. Only 35F5 was effective in abrogating the behavioral effect of IL-1 beta. Moreover, 4E2 (1 mu g icv) did not potentiate the behavioral response to a subthreshold dose of IL-1 beta (1 ng icv). To examine the ability of brain IL-1RI to mediate the effects of endogenous IL-1 beta, mice were centrally treated with 35F5 (4 mu g) and peripherally injected with IL-1 beta (1 mu g). Like IL-1 receptor antagonist (4 mu g icy), 35F5 abrogated the effects of IL-1 beta. These results suggest that brain IL-1RI mediates the behavioral effects of IL-1 beta in mice.
引用
收藏
页码:R735 / R740
页数:6
相关论文
共 30 条
[1]   INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY [J].
AREND, WP .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1445-1451
[2]  
BENVENISTE EN, 1992, NEUROIMMUNOENDOCRINO, P106
[3]  
BOSSU P, 1995, AM J PATHOL, V147, P1852
[4]   2 HIGH-AFFINITY INTERLEUKIN-1 RECEPTORS REPRESENT SEPARATE GENE-PRODUCTS [J].
CHIZZONITE, R ;
TRUITT, T ;
KILIAN, PL ;
STERN, AS ;
NUNES, P ;
PARKER, KP ;
KAFFKA, KL ;
CHUA, AO ;
LUGG, DK ;
GUBLER, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :8029-8033
[5]   THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1 [J].
COLOTTA, F ;
DOWER, SK ;
SIMS, JE ;
MANTOVANI, A .
IMMUNOLOGY TODAY, 1994, 15 (12) :562-566
[6]   INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4 [J].
COLOTTA, F ;
RE, F ;
MUZIO, M ;
BERTINI, R ;
POLENTARUTTI, N ;
SIRONI, M ;
GIRI, JG ;
DOWER, SK ;
SIMS, JE ;
MANTOVANI, A .
SCIENCE, 1993, 261 (5120) :472-475
[7]  
CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101
[8]  
DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517
[9]  
DINARELLO CA, 1992, INFLAMMATION BASIC P, P211
[10]   MONOCLONAL-ANTIBODY 1994-01 (ALSO KNOWN AS ALVA-42) REPORTED TO RECOGNIZE TYPE-II IL-1 RECEPTOR IS SPECIFIC FOR HLA-DR ALPHA-CHAIN AND BETA-CHAIN [J].
GAYLE, MA ;
SIMS, JE ;
DOWER, SK ;
SLACK, JL .
CYTOKINE, 1994, 6 (01) :83-86